Michigan Center for Diabetes Translational Research: Intervention and Technology Research Core

The Intervention and Technology Research Core provides three services to MCDTR investigators that are essential for the development of innovative translational research programs that can be implemented and maintained in real-world clinical and community settings:

  1. Consultation on content development and key technologies for high-impact translational interventions.
  2. Consultation on the broader evidence-base for translatable diabetes interventions.
  3. Access to already-developed patient-centered mHealth platforms. By building on the Core’s expertise in content development and the broader evidence-base for translatable diabetes interventions, and by leveraging already-available systems of hardware and software, the Core will assist MCDTR investigators to develop innovative programs rapidly and within realistic budgets. A goal of this Core is to make the infrastructure we have developed accessible to investigators within the University of Michigan, regionally, nationally, and internationally.

Key Personnel

John D. Piette, PhD, Director, Intervention and Technology Research Core and Associate Director, MCDTR
jpiette@umich.edu, 734-647-8160
Lawrence C. An, MD, Co-Investigator
lcan@umich.edu, 734-763-6099
Satinder Singh Baveja, PhD, Co-Investigator
fbaveja@umich.edu, 734-936-2831
Caroline R. Richardson, MD, Co-Investigator
caroli@umich.edu, 734-998-7120
Nicole Marinec, MPH, Coordinator
stecn@umich.edu, 734-845-3653
Sean Newman, MS, Programmer
scnewman@umich.edu, 734-936-2831

Remember to cite the Michigan Center for Diabetes Translational Research (MCDTR) in publications as follows:
“The project described was supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases”